Nuclear Medicine and Biology

Papers
(The TQCC of Nuclear Medicine and Biology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information63
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N59
[18F]BCPP-EF positron emission tomography of rat ovaries for evaluation of mitochondrial function40
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases37
Editorial Board32
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information26
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes23
Status of radiobiology in molecular radionuclide therapy – Hope for the future22
Targeted radioimmunotherapy of PD1+ cells for the treatment of multiple sclerosis22
DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers21
Trastuzumab-conjugated oxine-based ligand for [89Zr] Zr4+-immunoPET19
Epigenetic modifiers in somatostatin type 2 receptor radionuclide theranostics and early transcriptional response of mouse pheochromocytoma models18
PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models17
At-211-labeled L-tyrosine derivatives via neopentyl scaffold for targeted α-therapy17
Direct 18F fluorination of covalent organic framework (COF) nanosheets for PET molecular imaging17
Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging14
Evaluation of [18F]RM273 for sigma2-receptor imaging in an experimental orthotopic glioblastoma model14
Hypoxia targeting lutetium-177 labeled gold nanoparticles for cancer theranostic application14
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India14
Scandium exopolysaccharide complexes: evaluation of antiproliferative properties of on several cancer cell lines13
Development of a [18F]PD-L1 radiotracer to profile cancer patient response to immunotherapy13
Targeting LDLR-overexpressing glioblastoma and pancreatic ductal adenocarcinoma12
Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice12
Behind the scenes of Ga-68-Trivehexin development: unique structure-activity relationships12
CD46 targeted, Actinium-225 labelled antibody for treatment of prostate cancer xenografts11
A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination11
11C-Radiolabeling of α-amino acids via aldehyde-promoted isotopic exchange reaction11
Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease11
A clickable C-glycosyl scaffold for RGD peptide dimer labelling and application in bimodal [18F]PET/NIRF imaging10
Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer10
111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies10
TRIHOPO: 1,2-HOPO-based macrocyclic chelator for 225Ac, 227Th, and 89Zr10
Copper-mediated 18F-fluorination of boroxines: a systematic optimization study10
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-6410
Preparation of 211At-labeled aromatic compounds from thioarylprecursors10
GMP-compliant radiosynthesis of [18F]GP1 for the detection of thrombi9
Fluoride mediated radiosynthesis of [11C]methyl esters9
Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications9
[11C]Carboxylated tetrazines for facile labeling of trans-cyclooctene-functionalized macromolecules9
Simple method for the production of [11C]phosgene8
New way to refine direct aromatic 18F-labeling of tetrazines8
Bucherer-Bergs multicomponent reaction with [11C]CO2, a facile and divergent synthesis of 11C-labelled hydantoins8
Establishing the role of “Design of Experiments” (DoE) in the tracer development pipeline: the synthesis and evaluation of [18F] talazoparib as a case study8
Radiolabeling of hyaluronan and hyaluronan-αvβ6-Binding Peptide for PET imaging8
Carbamoyl fluoride as a potential new tag for 18F-labeling8
Alpha particle therapy for the treatment of metastatic tumors of prostate cancer7
Improved Synthesis of 3-[18F]Fluoro-p-Hydroxyphenethylguanidine ([18F]3F-PHPG) for Clinical Evaluation of Paraganglioma, Pheochromocytoma and Related Neuroendocrine Tumors7
Extraction of 68Ga medical radioisotopes from Zn nitrate liquid target using atomic layer deposited microfluidics7
Can the Radiochemical Purity of 225Ac-Labeled Compounds be Accurately Assessed by Radio-TLC Alone?7
Investigating the chemical scope of protein-ligation using photoactivatable chelates7
Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy7
Proof of principle: [18F]AlF radiolabelling using a droplet microreactor7
Synthesis of [18F]UCB-J7
Nanoparticles as a Radionuclide Generator System for 225Ac/213Bi6
64Cu-Lazarus: bringing our [64Cu]CuCl2 manufacturing system back to life6
Pharmacokinetic preclinical evaluation of radioligation strategies impact on antibody fragment targeting PD-L16
Synthesis of fluorine-18 labelled tetrazine and coupling to trans-cyclooctene functionalized Affibody molecules6
227Ac Content in Tri-Lab Accelerator-Produced 225Ac: 2023 Update6
Improved synthesis of [18F]FPATPP via Ru-mediated 18F-Fluorination6
Electronic cigarette aerosol deposition of [11C]nicotine in human subjects: radiosynthesis and vaping apparatus development5
Capsular reformulation of the PET radiopharmaceutical [18F]FTHA for oral administration5
Synthesis of gold nanoparticles labeled with Auger electron emitters: 197Hg/197mHg as potential therapeutic radiopharmaceuticals5
Evaluation of 3,4,3-LI(1,2-HOPO) as a chelator for radioscandium based radiopharmaceuticals5
Cationic pH-responsive albumin binding ligands (ABLs) for enhanced cancer-specific theranostics5
Ga-68-labelling of quinuclidine triazole-based compound5
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information5
A study to obtain a highly reproducible radiochemical yield (RCY) in the PSMA-11 radiolabeling5
Comparison of DOTA, NODAGA and 15-5 macrocycles as chelators for 64Cu-labelling of immunoconjugates5
Evaluation of biodistribution of a novel sugar-conjugated platinum complex labeled with 191Pt in mice5
Silicon-based Fluoride Acceptor (SiFA) on solid supports: a new versatile tool for 18F-fluorination of peptides and biological structures4
Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression4
Synthesis and optimization of radiotracers targeting P2Y12 receptors for positron emission tomography imaging of neuroinflammation4
StarPEG Nanocarriers for PSMA Targeted Radioligand Imaging and Therapy4
Synthesis and in vitro stability evaluation of Cu-64 labeled branched polyethyleneimine (BPEI)4
A fluorescent probe as a lead compound for a potential α-syn PET tracer: design and development of a library of RB1 derivatives4
Lanatoside C enhances 131I-rituximab treatment in Raji lymphoma cells4
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism4
Automated radiosynthesis of the 18F-labeled BF2-chelated tetraaryl-azadipyrromethenes photosensitizer using isotopic exchange4
Evaluation of the therapeutic effect of taurine against Alzheimer’s disease using mGluR5 PET4
Synthesis and evaluation of an 18F labeled conformationally flexible benzamide analog ([18F]Fluoroethyl HY-2-92) for D3R PET Studies4
Development of novel 64Cu-labelled antibodies for PET-CT imaging of TREM24
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics4
Quantitative Evaluation of a Novel PET Radioligand for the Monoacylglycerol Lipase (MAGL) in Non-Human Primates3
Evaluation of [18F]FMTEB in Sprague Dawley rats as a PET tracer for metabotropic glutamate receptor 53
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors3
Optimized Radiosynthesis of Racemic 2-[18F]Fluoropropionic Acid for PET Imaging of Incipient Heart Failure3
Editorial Board3
Enantioselective Synthesis and Biological Evaluation of (R)- and (S)-[18F]OF-NB1 to Visualize GluN2B Subunit-Containing NMDA Receptors3
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging3
Development of Approaches for High-Throughput Experimentation in Radiochemistry3
Preparation and labelling of red blood cells with [68Ga]Ga-oxine for PET/CT imaging of the human spleen3
Combining Positron Emission Tomography and Hyperpolarized Magnetic Resonance to Interrogate Prostate Cancer Metabolism3
A rapid non-radiometric LC-MS/MS procedure for measuring the molar activity of cyclotron-produced [18F]fluoride3
NANOCIS®: Possible errors in the summary of product characteristics quality control method and a suggested alternative method3
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter3
A Novel Prosthetic group, 4-[18F]Fluorophenylglyoxal for Protein Conjugation3
CD133-Targeted Radioimmunotherapy of Small Cell Lung Cancer3
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy3
Imaging acute and chronic stress using 2-[18F]FDG PET2
Comparing the day-to-day production of [68Ga]Ga-PSMA-11 using Locametz and Illuccix Kits2
Radiosynthesis of [18F]AmBF3-Tyr3-Octreotides with Tetrazine Ligation Based on the Inverse Electron-Demand Diels–Alder Reaction: Rapid, Catalyst-free and Mild Conversion of 1,4-Dihydropyridazines to P2
Reports on the advancements of organotrifluoroborates and their use in PET imaging2
Evaluation of Iododiflunisal on amyloid-β deposition in 5xFAD Alzheimer’s disease mouse model by Positron Emission Tomography imaging.2
Comparison of two cyclen-based phosphonates for development of bone-seeking lutetium-177 radiopharmaceuticals2
Blood–brain barrier penetrating peptide-based radioligands targeting the EGFR:EGFRvIII receptors2
Density functional theory experiments offer insight into properties of the Sc-HOPO complex2
[177Lu]Lu-labeled NaGdF4:Ho-Yb@m-SiO2 upconversion nanophosphors: synthesis and characterization as a potent theranostic probe2
Technetium and rhenium complexes with potential against glioblastomas2
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-742
PAM and FUS-assisted local AAV gene delivery into the brain of Alzheimer’s disease murine models assessed by quantitative PET reporter gene2
Evaluation of (R)- and (S)-18F-PF-NB1 in non-human primates for imaging the GluN2B subunits of NMDA receptor complex2
Neuroimaging of p38 MAPK with [11C]SCIO-469 Enabled by Inhibition of P-glycoprotein2
Radiopharmaceutical production and stability studies of 18F-rhPSMA-7.3 injection on a Siemens Explora GN Synthesis Module2
Imidazolium Salt-Mediated Radiofluorosulfurylation to Produce 18F-labeled Aryl Fluorosulfates2
O-[18F]fluoroalkylation of phenol derivatives with [18F] epifluorohydrin in the presence of t-Bu-P4 base2
Radiosynthesis and preclinical evaluation of [11C]mitragynine isotopomers in rodents2
Development of targeted 161Tb-radiolabeled nanoparticles2
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-642
Radiolabeled peptidomimetic inhibitors of the VEGF:NRP-1 complex as diagnostic: therapeutic radiopharmaceuticals2
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-1882
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.2
A novel synthesis of [11C]FTIMD2
Comparison of the syntheses of 18F-labelled norepinerphrine transporter tracer [18F]NS12137 using in-house built device and Trasis AllinOne2
First in-human studies of the glutamate transporter EAAT2 radiotracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparginate (RP-115): radiosynthesis and biodistribution evaluation2
Synthesis of [18F]FAraG Using a Second-Generation Precursor and Its Utility Across Multiple Radiochemistry Platforms2
Evaluation of a Radiofluorinated Probe for Imaging Cytochrome P450 46A12
Antimicrobial peptide form native plant Erythrina crista-galli: a promising agent for diagnostic of infection foci2
[18F]FEPPA PET imaging for monitoring the neuroinflammation status in a Lactacystin-induced Parkinson disease animal model.2
Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study2
The CERN-MEDICIS facility: a radioisotope production facility for medical applications2
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks2
Development of versatile dual-modality imaging probes based on a GRPR antagonist for preoperative imaging and image-guided surgery of prostate cancer1
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation1
Automated radiosynthesis of [18F]AlF-FAPI-421
Production, purification and formulation of nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy1
In vivo assessment of TNF-a expression by SPECT/CT antibod imaging using click chemistry in mice models of rheumatoid arthritis1
Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues1
Reductive N-11C-methylation of anilines in dimethyl sulfoxide using in situ generated [11C]formaldehyde and 2-methylpyridine-borane1
Implementation of iMiDEV, a new fully automated microfluidic platform for radiopharmaceutical production1
Editorial Board1
[18F]Talazoparib: a novel potential PET imaging agent of PARP1
Radiopharmacological comparison of an Al18F- and 68Ga-labeled somatostatin agonist and antagonist in 2D and 3D models of BON-SSTR2 cells1
In vitro Characterizations of an S1PR1 Specific Radioligand [3H] CS1P1 in the Central Nervous System1
PET imaging of PD-L1 overexpressing tumors with a 68Ga labeled D-dodecapeptide1
Targeting mammary-derived growth inhibitor for positron emission tomography imaging of breast cancer brain metastasis1
Preliminary evaluation of a novel carbon-11 labeled brain-penetrant EGFR-TKI radiotracer for brain cancer imaging1
PET imaging of neurotensin receptor-positive tumors with 68Ga-labeled antagonists: “the chelate makes again the difference”1
Abstract converted to P-851
Noninvasive imaging of STING expression in tumor microenvironment using radioiodinated small molecule1
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information1
Synthesis and preliminary in-vitro studies of [99mTc][TcN(PNP)]-biphosphonates as new bone-radiopharmaceuticals.1
An approach towards reverse generator system for 99mTc separation from LSA 99Mo1
Specific imaging of bacterial infections with 18F-labeled maltotriose ([18F]AAX90)1
Original 18F-thiol prosthetic group for labeling of dehydroalanine-containing biologics1
Stabilization of 68Ga-labeled [Thz14]Bombesin(7–14) analogue for imaging gastrin-releasing peptide receptor expression with positron emission tomography1
Sortase mediated conjugation and 89Zr-radiolabelling of the HER2 neu targeting G3-DARPin for in vivo PET imaging in BT-474-xenografts1
High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging1
Development of [18F]Fluoromannitol, a Novel Radiopharmaceutical for Infection Imaging1
Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM261
Radiolabeling of two different precursors of m-[211At] astatobenzylguanidine using 211At purified by wet extraction.1
Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers1
Preclinical characterization of [18F]FB-labeled single-domain antibodies for PET imaging of FAP-α or Folate-α overexpression in cancer1
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer1
Tumor-specific delivery of radioligands targeting carbonic anhydrase-IX utilizing albumin binder1
HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study1
Development of a novel 68Ga-labeled benzo[h]quinoline-based FAP-targeted PET tracer: Synthesis, preclinical evaluation, and comparison with [68Ga]Ga-FAPI-041
225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation1
ALISI – automated light-induced synthesis of 89Zr-labelled antibodies for immuno-PET1
Development of five Polar and Highly Reactive Tetrazines for Pretargeted Imaging1
Alternate radiohalogens for trametinib PET imaging1
Identification of non-competitive lead peptides for the development of PET tracers targeting PD-L11
Development of 68Ga-labeled riboflavin analognes for RFVTs-targeted PET imaging1
Molecular imaging of murine liver fibrosis with sphingosine-1-phosphate receptor 1 targeted PET ligand1
Production of high-specific-activity erbium-169, ytterbium-175 and thulium-1671
Evaluation of [18F]FPy-T140 derivative PET imaging agents for CXCR4 in human cancer xenograft mouse models1
Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands1
Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations1
Determination of 2-chloro-2-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and glucose in [18F]Fluorodeoxyglucose by capillary electrophoresis1
A Preclinical Platform to Thoroughly Evaluate Novel Nanocomposites in the Full Spectrum of Drug Discovery (in vitro - in vivo - ex vivo) Towards Cancer Treatment1
Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP1
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information1
ABSTRACT REVIEWERS1
Simple and rapid automated synthesis of L-[11C]glutamine1
Fluorine-mediated desilylative Carbon-11 carboxylation of acylsilanes with [11C]CO2 for the radiosynthesis of [1-11C]α-keto acids1
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/1
A comparison of rhenium isolation and tungsten recovery methods from bulk tungsten targets1
Identifying Toxicity Mechanisms Associated with f-block Radiometals through Genome-wide Toxicogenomics1
Photoaffinity labeling for the site-specific bioconjugation of 89Zr-labeled radioimmunoconjugates1
Development of bispecific theranostic ligand targeting the prostate specific membrane antigen (PSMA) and gastrin releasing peptide (GRPR) receptor1
Synthesis, radiolabelling and complex formation of the novel chelator DOTI-Me with Cu, In, Ga1
Performance assessment of quantitative preclinical SPECT imaging with 155Tb and 161Tb1
Development of silicon fluoride acceptor (SiFA)-conjugated antibodies targeting TREM2 and Poly-GA repeats as new tracers for PET imaging of neurodegenerative diseases1
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry1
Radiolabeling of HER2 targeting single domain antibody with Tc-99m and Re-1881
Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonist for PET imaging1
89Zr-immuno-PET imaging: from liquid target production to imaging1
A new rhenium/technetium-99m complex bearing a quinazoline derivative and 2-picolylamine-N-acetic acid for EGFR imaging1
Trafficking of orally administered vitamins in mice with positron emission tomography1
New extractant-impregnated iTLC-SG paper facilitates improved TLC analysis for Cu radiolabelled peptides1
Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging1
Preparation of electrodeposited UO2 target for fission-99Mo production1
Radiosynthesis and biological evaluation of [18F]AG-120 as imaging agent for the detection of the mutant isocitrate dehydrogenase 1 in glioma by PET1
Automated radiosynthesis of [18F]DOPA and [18F]FMT via copper-mediated nucleophilic F-18 Fluorination of arylstannanes on a new synthesizer0
Organotin derivatives as versatile precursors for the radioiodination and radiofluorination of 1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid (TIC(OH)) analogues0
Preclinical validation of [18F]-FB-(Anti Human PD-L1) nanobody for PET imaging0
Preparation of a 18F-labeled COX-2 inhibitor via [18F]SuFEx reaction0
First-In-Class Diagnostics Targeting Neuropeptide Y1 Receptor (Y1R): Enabling Molecular Imaging of Metastatic Breast Cancer0
The influence of terminal amine groups in close proximity to the metal chelator in peptide derived radiopharmaceuticals on the radiolabelling with 68Ga and 64Cu0
Author Index0
The development of a dual-modality (PET/NIR) radioimmunoconjugate for image-guided sarcoma surgery0
Synthesis of radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 10
Molecular imaging of PSA using DARPin scaffolds0
Highly automated solid target-based production of the emerging PET isotope cobalt-550
Fluoroquinolone dithiocarbamate rhenium and technetium-99m complexes for potential infection imaging agents0
Towards pretargeted PET imaging of Programmed Death Ligand 1 (PD-L1) with a gallium-68-labeled tris(hydroxypyridinone)-tetrazine0
Pressed chromium/sodium fluoride target for cyclotron production of manganese-520
Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F0
Editorial Board0
In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK62400
Trans-cyclooctene modified antibodies for pretargeted imaging of amyloid-β0
Copper-61 as an alternative to Gallium-68 for radiopharmaceutical production: feasibility study and scale-up for clinical doses0
Cancer theranostics using radiolabelled PARP inhibitors0
Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker0
Evaluation of the effect of macrocyclic ring size on Pb(II) and Cu(II) complex stability in pyridyl containing chelators0
Development of a dual imaging probe for bimodal PET/ two-photon NIRF imaging0
Radioisotope-loaded microbubbles for cancer imaging and therapy0
Aryliodonium ylides as efficient precursors for astatine-211 labeling0
Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts0
Development of novel tripodal chelates for the stable chelation of theranostic radiolanthanides and actinides0
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis0
Exploration of the fundamental chemistries of Ru and Pd for establishing 103Ru/103mRh Auger generator and 103Pd/103mRh in vivo generator0
A pyrene-phthalocyanine conjugate for dual Cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy0
Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 d0
Design and synthesis of a new bifunctional chelating agent for 18F-Al/177Lu radiolabelling: theranostic approach0
Automated purification of radiometals produced by solid targets0
Chemically Identical Pair of Theranostic Small-Molecule Drug Conjugates for Prostate Cancer Imaging and Chemotherapy0
Production of 89Zr from cyclotron using yttrium foil: a new target design0
Water-soluble [Tc(N)(PNP)]-moiety for the room temperature labeling of sensitive molecules0
A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben0
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives0
Cyclotron-production of Mn-52: an update on the METRICS project0
SCIFI: exciting BODIPY compounds with 89Zr-generated Cerenkov radiation0
Development of 18F-labeled tracer for noninvasive PET imaging of the STING expression in tumor microenvironment0
Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists0
Synthetic methodologies toward fibroblast activation protein inhibitors and radiolabelling with 68Ga, 64Cu or 89Zr0
DOX-PEG-198AuNPs-PEG-Tmab: multimodal radiobioconjugate for targeted radionuclide therapy of HER2-positive cancers0
Carbon-11 labelled isocyanides: new versatile building blocks to access novel PET tracers0
A convenient tritiation strategy for tetrazines0
Optimization and scale-up of [68Ga]Ga-FAPI-46 production on a Modular-Lab PharmTracer platform for clinical application0
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer0
0.080600023269653